Systematic review and meta-analysis of 164 studies: global anti-PT IgG seroprevalence was 23.39% in 2010-2023 and estimated B. pertussis infection incidence 5.11%, up to 386 million cases a year; acellular-vaccine regions had lower estimated infection rates than whole-cell.
Meta-analysisn = 164 studies
Ma et al. A global systematic literature review of Bordetella pertussis anti-PT IgG seroprevalence 2010 to 2023